OTTAWA, Jan. 24, 2018 /CNW/ - National Access Cannabis Corp. ("NAC" or the "Company") (TSX VENTURE: NAC), Canada's best practices leader in delivering secure, safe, and responsible access to legal medical cannabis today announced that it has granted stock options (the "Options") entitling an officer of the Corporation to acquire up to 60,000 common shares of the Corporation for a period of five years from the date of grant of the Options. The Options will vest over twelve months, with 15,000 of the Options vesting immediately upon grant and an additional 15,000 vesting in each of the three quarters that follow thereafter. The Options were granted as of January 15, 2018 at an exercise price of $0.55 per common share.
About National Access Cannabis
NAC is Canada's best practices leader in delivering secure, safe, and responsible access to legal medical cannabis. NAC enables patients to gain knowledge and the legal medical documentation required to navigate Canada's disparate network of authorized Licensed Producers of Cannabis. Through its Canada-wide network of care centres, NAC has partnered with health professionals to improve the quality of life of its local members and provide services designed to inform, educate and supply expert advice. For more information, visit www.nationalaccesscannabis.com or refer to the NAC's profile on the SEDAR website at www.sedar.com.
National Access Cannabis Corp. is listed on the TSX Venture Exchange under the symbol (TSXV: NAC).
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
SOURCE National Access Cannabis Corp.
For further information: National Access Cannabis Corp., Mark Goliger, Chief Executive Officer, 1 (800) 411-1126, [email protected]; Investor Relations, Robert Kelly, LodeRock Advisors Inc., (416) 992-4539, [email protected]